ANTILYMPHOCYTE THERAPY IN KIDNEY TRANSPLANTATION: A PROSPECTIVE RANDOMIZED TRIAL OF FULL-DOSE RABBIT ANTI-HUMAN THYMOCYTE GLOBULIN (RATG) VERSUS LOW-DOSE RATG AND BASILIXIMAB
I Codreanu; P Cravedi; P Ruggenenti; G Remuzzi
Author Information: Mario Negri Institute for Pharmacological Research, Bergamo, Italy,
| Checking for direct PDF access through Ovid | ||